1. T.S. Assmann, M. Recamonde-Mendoza, B.M. de Souza, A.C. Bauer, D. Crispim, MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis, Molecular and cellular endocrinology 477 (2018) 90-102.
2. L. Zhang, J. Long, W. Jiang, Y. Shi, X. He, Z. Zhou, Y. Li, R.O. Yeung, J. Wang, K. Matsushita, J. Coresh, M.H. Zhao, H. Wang, Trends in Chronic Kidney Disease in China, The New England journal of medicine 375(9) (2016) 905-6.
3. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S.Y. Ahn, M. Alvarado, H.R. Anderson, L.M. Anderson, K.G. Andrews, C. Atkinson, L.M. Baddour, S. Barker-Collo, D.H. Bartels, M.L. Bell, E.J. Benjamin, D. Bennett, K. Bhalla, B. Bikbov, A. Bin Abdulhak, G. Birbeck, F. Blyth, I. Bolliger, S. Boufous, C. Bucello, M. Burch, P. Burney, J. Carapetis, H. Chen, D. Chou, S.S. Chugh, L.E. Coffeng, S.D. Colan, S. Colquhoun, K.E. Colson, J. Condon, M.D. Connor, L.T. Cooper, M. Corriere, M. Cortinovis, K.C. de Vaccaro, W. Couser, B.C. Cowie, M.H. Criqui, M. Cross, K.C. Dabhadkar, N. Dahodwala, D. De Leo, L. Degenhardt, A. Delossantos, J. Denenberg, D.C. Des Jarlais, S.D. Dharmaratne, E.R. Dorsey, T. Driscoll, H. Duber, B. Ebel, P.J. Erwin, P. Espindola, M. Ezzati, V. Feigin, A.D. Flaxman, M.H. Forouzanfar, F.G. Fowkes, R. Franklin, M. Fransen, M.K. Freeman, S.E. Gabriel, E. Gakidou, F. Gaspari, R.F. Gillum, D. Gonzalez-Medina, Y.A. Halasa, D. Haring, J.E. Harrison, R. Havmoeller, R.J. Hay, B. Hoen, P.J. Hotez, D. Hoy, K.H. Jacobsen, S.L. James, R. Jasrasaria, S. Jayaraman, N. Johns, G. Karthikeyan, N. Kassebaum, A. Keren, J.P. Khoo, L.M. Knowlton, O. Kobusingye, A. Koranteng, R. Krishnamurthi, M. Lipnick, S.E. Lipshultz, S.L. Ohno, J. Mabweijano, M.F. MacIntyre, L. Mallinger, L. March, G.B. Marks, R. Marks, A. Matsumori, R. Matzopoulos, B.M. Mayosi, J.H. McAnulty, M.M. McDermott, J. McGrath, G.A. Mensah, T.R. Merriman, C. Michaud, M. Miller, T.R. Miller, C. Mock, A.O. Mocumbi, A.A. Mokdad, A. Moran, K. Mulholland, M.N. Nair, L. Naldi, K.M. Narayan, K. Nasseri, P. Norman, M. O'Donnell, S.B. Omer, K. Ortblad, R. Osborne, D. Ozgediz, B. Pahari, J.D. Pandian, A.P. Rivero, R.P. Padilla, F. Perez-Ruiz, N. Perico, D. Phillips, K. Pierce, C.A. Pope, 3rd, E. Porrini, F. Pourmalek, M. Raju, D. Ranganathan, J.T. Rehm, D.B. Rein, G. Remuzzi, F.P. Rivara, T. Roberts, F.R. De Leon, L.C. Rosenfeld, L. Rushton, R.L. Sacco, J.A. Salomon, U. Sampson, E. Sanman, D.C. Schwebel, M. Segui-Gomez, D.S. Shepard, D. Singh, J. Singleton, K. Sliwa, E. Smith, A. Steer, J.A. Taylor, B. Thomas, I.M. Tleyjeh, J.A. Towbin, T. Truelsen, E.A. Undurraga, N. Venketasubramanian, L. Vijayakumar, T. Vos, G.R. Wagner, M. Wang, W. Wang, K. Watt, M.A. Weinstock, R. Weintraub, J.D. Wilkinson, A.D. Woolf, S. Wulf, P.H. Yeh, P. Yip, A. Zabetian, Z.J. Zheng, A.D. Lopez, C.J. Murray, M.A. AlMazroa, Z.A. Memish, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet (London, England) 380(9859) (2012) 2095-128.
4. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet (London, England) 395(10225) (2020) 709-733.
5. D. Giugliano, M.I. Maiorino, G. Bellastella, K. Esposito, Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59, Diabetes care 39(6) (2016) e86-7.
6. E. Dounousi, A. Duni, K. Leivaditis, V. Vaios, T. Eleftheriadis, V. Liakopoulos, Improvements in the Management of Diabetic Nephropathy, The review of diabetic studies : RDS 12(1-2) (2015) 119-33.
7. S. Li, S. Xutian, New Development in Traditional Chinese Medicine: Symbolism-Digit Therapy as a Special Naturopathic Treatment, The American journal of Chinese medicine 44(7) (2016) 1311-1323.
8. S. Li, B. Zhang, N. Zhang, Network target for screening synergistic drug combinations with application to traditional Chinese medicine, BMC systems biology 5 Suppl 1 (2011) S10.
9. J.B. Fitzgerald, B. Schoeberl, U.B. Nielsen, P.K. Sorger, Systems biology and combination therapy in the quest for clinical efficacy, Nature chemical biology 2(9) (2006) 458-66.
10. P. Csermely, V. Agoston, S. Pongor, The efficiency of multi-target drugs: the network approach might help drug design, Trends in pharmacological sciences 26(4) (2005) 178-82.
11. Z. Lu, Y. Zhong, W. Liu, L. Xiang, Y. Deng, The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease, Journal of diabetes research 2019 (2019) 2697672.
12. P. Li, Y. Chen, J. Liu, J. Hong, Y. Deng, F. Yang, X. Jin, J. Gao, J. Li, H. Fang, G. Liu, L. Shi, J. Du, Y. Li, M. Yan, Y. Wen, W. Yang, Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial, PloS one 10(5) (2015) e0126027.
13. J. Lv, Z. Wang, Y. Wang, W. Sun, J. Zhou, M. Wang, W.J. Liu, Y. Wang, Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-alpha/NF-kappaB Signaling Pathway in Diabetic Rats, Journal of diabetes research 2017 (2017) 4319057.
14. J. Ru, P. Li, J. Wang, W. Zhou, B. Li, C. Huang, P. Li, Z. Guo, W. Tao, Y. Yang, X. Xu, Y. Li, Y. Wang, L. Yang, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, Journal of cheminformatics 6 (2014) 13.
15. J.S. Amberger, A. Hamosh, Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes, Current protocols in bioinformatics 58 (2017) 1.2.1-1.2.12.
16. H. Wang, X. Liu, Y. Tao, W. Ye, Q. Jin, W.W. Cohen, E.P. Xing, Automatic Human-like Mining and Constructing Reliable Genetic Association Database with Deep Reinforcement Learning, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 24 (2019) 112-123.
17. W. Huang da, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature protocols 4(1) (2009) 44-57.
18. L. Chen, Y.H. Zhang, S. Wang, Y. Zhang, T. Huang, Y.D. Cai, Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways, PloS one 12(9) (2017) e0184129.
19. J.F. Navarro, C. Mora, M. Maca, J. Garca, Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus, American journal of kidney diseases : the official journal of the National Kidney Foundation 42(1) (2003) 53-61.
20. F. Cosentino, M. Eto, P. De Paolis, B. van der Loo, M. Bachschmid, V. Ullrich, A. Kouroedov, C. Delli Gatti, H. Joch, M. Volpe, T.F. Luscher, High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species, Circulation 107(7) (2003) 1017-23.
21. S. Prabhakar, J. Starnes, S. Shi, B. Lonis, R. Tran, Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production, Journal of the American Society of Nephrology : JASN 18(11) (2007) 2945-52.
22. E.A. Jaimes, P. Hua, R.X. Tian, L. Raij, Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress, American journal of physiology. Renal physiology 298(1) (2010) F125-32.
23. A. Kuwabara, M. Satoh, N. Tomita, T. Sasaki, N. Kashihara, Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats, Diabetologia 53(9) (2010) 2056-65.
24. H. Qi, G. Casalena, S. Shi, L. Yu, K. Ebefors, Y. Sun, W. Zhang, V. D'Agati, D. Schlondorff, B. Haraldsson, E. Bottinger, I. Daehn, Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility, Diabetes 66(3) (2017) 763-778.
25. Y. Kim, C.W. Park, Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease, International journal of molecular sciences 20(7) (2019).
26. C. Liu, J.D. Lin, PGC-1 coactivators in the control of energy metabolism, Acta biochimica et biophysica Sinica 43(4) (2011) 248-57.
27. C. Handschin, B.M. Spiegelman, Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism, Endocrine reviews 27(7) (2006) 728-35.
28. M. Tran, S.M. Parikh, Mitochondrial biogenesis in the acutely injured kidney, Nephron. Clinical practice 127(1-4) (2014) 42-5.
29. F.B. Hickey, J.B. Corcoran, N.G. Docherty, B. Griffin, U. Bhreathnach, F. Furlong, F. Martin, C. Godson, M. Murphy, IHG-1 promotes mitochondrial biogenesis by stabilizing PGC-1alpha, Journal of the American Society of Nephrology : JASN 22(8) (2011) 1475-85.
30. B. Nambam, D. Schatz, Growth hormone and insulin-like growth factor-I axis in type 1 diabetes, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 38 (2018) 49-52.
31. L.A. Bach, L.J. Hale, Insulin-like growth factors and kidney disease, American journal of kidney diseases : the official journal of the National Kidney Foundation 65(2) (2015) 327-36.
32. M.Y. Donath, Multiple benefits of targeting inflammation in the treatment of type 2 diabetes, Diabetologia 59(4) (2016) 679-82.
33. J. Li, R. Dong, J. Yu, S. Yi, J. Da, F. Yu, Y. Zha, Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2, Drug design, development and therapy 12 (2018) 2887-2896.
34. J.C. Timmer, G.S. Salvesen, Caspase substrates, Cell death and differentiation 14(1) (2007) 66-72.
35. S.J. Riedl, Y. Shi, Molecular mechanisms of caspase regulation during apoptosis, Nature reviews. Molecular cell biology 5(11) (2004) 897-907.
36. N. Miao, F. Yin, H. Xie, Y. Wang, Y. Xu, Y. Shen, D. Xu, J. Yin, B. Wang, Z. Zhou, Q. Cheng, P. Chen, H. Xue, L. Zhou, J. Liu, X. Wang, W. Zhang, L. Lu, The cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury, Kidney international 96(5) (2019) 1105-1120.
37. Z. Zhang, X. Shao, N. Jiang, S. Mou, L. Gu, S. Li, Q. Lin, Y. He, M. Zhang, W. Zhou, Z. Ni, Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury, Cell death & disease 9(10) (2018) 983.
38. K. Susztak, A.C. Raff, M. Schiffer, E.P. Bottinger, Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy, Diabetes 55(1) (2006) 225-33.
39. Y. Wang, W. Gao, X. Shi, J. Ding, W. Liu, H. He, K. Wang, F. Shao, Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin, Nature 547(7661) (2017) 99-103.
40. S. Wen, Z.H. Wang, C.X. Zhang, Y. Yang, Q.L. Fan, Caspase-3 Promotes Diabetic Kidney Disease Through Gasdermin E-Mediated Progression to Secondary Necrosis During Apoptosis, Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020) 313-323.
41. E. Lupia, S.J. Elliot, O. Lenz, F. Zheng, M. Hattori, G.E. Striker, L.J. Striker, IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy, Diabetes 48(8) (1999) 1638-44.
42. P. Catanuto, X. Xia, S. Pereira-Simon, S. Elliot, Estrogen receptor subtype ratio change protects against podocyte damage, Current trends in endocrinology 9 (2017) 19-29.
43. R. Kooijman, Regulation of apoptosis by insulin-like growth factor (IGF)-I, Cytokine & growth factor reviews 17(4) (2006) 305-23.
44. R.T. Kurmasheva, P.J. Houghton, IGF-I mediated survival pathways in normal and malignant cells, Biochimica et biophysica acta 1766(1) (2006) 1-22.
45. J. Boucher, Y. Macotela, O. Bezy, M.A. Mori, K. Kriauciunas, C.R. Kahn, A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis, Science signaling 3(151) (2010) ra87.
46. A. Chawla, E.J. Schwarz, D.D. Dimaculangan, M.A. Lazar, Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation, Endocrinology 135(2) (1994) 798-800.
47. T. Yang, D.E. Michele, J. Park, A.M. Smart, Z. Lin, F.C. Brosius, 3rd, J.B. Schnermann, J.P. Briggs, Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney, The American journal of physiology 277(6) (1999) F966-73.
48. S. Tiwari, V.K. Halagappa, S. Riazi, X. Hu, C.A. Ecelbarger, Reduced expression of insulin receptors in the kidneys of insulin-resistant rats, Journal of the American Society of Nephrology : JASN 18(10) (2007) 2661-71.
49. Q.N. Diep, M. El Mabrouk, J.S. Cohn, D. Endemann, F. Amiri, A. Virdis, M.F. Neves, E.L. Schiffrin, Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma, Circulation 105(19) (2002) 2296-302.
50. S. Ohga, K. Shikata, K. Yozai, S. Okada, D. Ogawa, H. Usui, J. Wada, Y. Shikata, H. Makino, Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation, American journal of physiology. Renal physiology 292(4) (2007) F1141-50.
51. T. Okada, J. Wada, K. Hida, J. Eguchi, I. Hashimoto, M. Baba, A. Yasuhara, K. Shikata, H. Makino, Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms, Diabetes 55(6) (2006) 1666-77.
52. Y. Miyazaki, E. Cersosimo, C. Triplitt, R.A. DeFronzo, Rosiglitazone decreases albuminuria in type 2 diabetic patients, Kidney international 72(11) (2007) 1367-73.
53. A. Gumieniczek, Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits, Life sciences 74(5) (2003) 553-62.
54. H. Zhang, S. Zhu, J. Chen, Y. Tang, H. Hu, V. Mohan, R. Venkatesan, J. Wang, H. Chen, Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies, Diabetes care 35(6) (2012) 1388-93.
55. X. Yang, X. Xiao, H. Wang, Y. Li, L. Wang, G. Li, S. Deng, Renoprotective Effect of Danhong Injection on Streptozotocin-Induced Diabetic Rats through a Peroxisome Proliferator-Activated Receptor gamma Mediated Pathway, Evidence-based complementary and alternative medicine : eCAM 2018 (2018) 3450141.
56. L. Zhang, J. Liu, F. Zhou, W. Wang, N. Chen, PGC-1alpha ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism, Molecular medicine reports 17(3) (2018) 4490-4498.
57. R. Dong, J. Yu, F. Yu, S. Yang, Q. Qian, Y. Zha, IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model, American journal of physiology. Endocrinology and metabolism 317(4) (2019) E686-e698.
58. D.Z. Cherney, J.W. Scholey, E. Sochett, T.J. Bradley, H.N. Reich, The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study, Diabetes care 34(1) (2011) 177-80.
59. D.Z. Cherney, H.N. Reich, J.W. Scholey, D. Daneman, F.H. Mahmud, R.L. Har, E.B. Sochett, The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes, Diabetologia 56(10) (2013) 2308-17.
60. T. Chawla, D. Sharma, A. Singh, Role of the renin angiotensin system in diabetic nephropathy, World journal of diabetes 1(5) (2010) 141-5.
61. R. Shaikh, S.M. Shahid, Q. Mansoor, M. Ismail, A. Azhar, Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy, Journal of the renin-angiotensin-aldosterone system : JRAAS 15(2) (2014) 124-30.
62. Z. Rahimi, A. Vaisi-Raygani, Z. Rahimi, A. Parsian, Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran, Nephrology (Carlton, Vic.) 17(2) (2012) 175-81.
63. R. El-Baz, A. Settin, A. Ismaeel, A.A. Khaleel, T. Abbas, W. Tolba, W. Abd Allah, M.A. Sobh, MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients, Journal of the renin-angiotensin-aldosterone system : JRAAS 13(4) (2012) 472-7.
64. Y. Wang, W. Peng, X. Zhang, H. Qiao, L. Wang, Z. Xu, C. Wu, The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan, Journal of the renin-angiotensin-aldosterone system : JRAAS 17(3) (2016).
65. F.R. Cheng, H.X. Cui, J.L. Fang, K. Yuan, Y. Guo, Ameliorative Effect and Mechanism of the Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. on Type 2 Diabetes Mellitus, Molecules (Basel, Switzerland) 24(8) (2019).
66. H.X. Cui, L.S. Zhang, Y. Luo, K. Yuan, Z.Y. Huang, Y. Guo, A Purified Anthraquinone-Glycoside Preparation From Rhubarb Ameliorates Type 2 Diabetes Mellitus by Modulating the Gut Microbiota and Reducing Inflammation, Frontiers in microbiology 10 (2019) 1423.
67. D. Jing, H. Bai, S. Yin, Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3beta and Bax/caspase-3 signaling pathways, Experimental and therapeutic medicine 14(5) (2017) 5163-5169.
68. P. Li, Q. Lu, W. Jiang, X. Pei, Y. Sun, H. Hao, K. Hao, Pharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 91 (2017) 425-435.
69. H. Sanada, [Study on the clinical effect of rhubarb on nitrogen-metabolism abnormality due to chronic renal failure and its mechanism], Nihon Jinzo Gakkai shi 38(8) (1996) 379-87.
70. M.T. Boroushaki, S. Fanoudi, H. Mollazadeh, S. Boroumand-Noughabi, A. Hosseini, Reno-protective effect of Rheum turkestanicum against gentamicin-induced nephrotoxicity, Iranian journal of basic medical sciences 22(3) (2019) 328-333.
71. G.X. Shui, D. Sang, X. Yin, Y. Cai, W. Sun, Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy, Evidence-based complementary and alternative medicine : eCAM 2017 (2017) 9536458.
72. Y. Tu, W. Sun, Y.G. Wan, K. Gao, H. Liu, B.Y. Yu, H. Hu, Y.R. Huang, Dahuang Fuzi Decoction ameliorates tubular epithelial apoptosis and renal damage via inhibiting TGF-beta1-JNK signaling pathway activation in vivo, Journal of ethnopharmacology 156 (2014) 115-24.
73. Y. Zheng, G.Y. Cai, L.Q. He, H.L. Lin, X.H. Cheng, N.S. Wang, G.H. Jian, X.S. Liu, Y.N. Liu, Z.H. Ni, J.A. Fang, H.L. Ding, W. Guo, Y.N. He, L.H. Wang, Y.P. Wang, H.T. Yang, Z.M. Ye, R.H. Yu, L.J. Zhao, W.H. Zhou, W.G. Li, H.J. Mao, Y.L. Zhan, Z. Hu, C. Yao, R.B. Wei, X.M. Chen, Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study, Chinese medical journal 130(20) (2017) 2402-2409.
74. X.L. Zhu, Y.J. Wang, Y. Yang, R.C. Yang, B. Zhu, Y. Zhang, Y. Lin, Y. Lu, X.F. Li, K.T. O'Byrne, Suppression of lipopolysaccharide-induced upregulation of toll-like receptor 4 by emodin in mouse proximal tubular epithelial cells, Molecular medicine reports 6(3) (2012) 493-500.
75. W. Zhang, H. Li, H. Bu, H. Chen, H. Tong, D. Liu, H. Guo, S.Z. Lin, Emodin inhibits the differentiation and maturation of dendritic cells and increases the production of regulatory T cells, International journal of molecular medicine 29(2) (2012) 159-64.
76. S. Xiong, S. Lei, Simultaneous Determination of Five Active Components in the Chinese Patent Medicine Niuhuang Jiangya Pill by HPLC-MS/MS, Journal of AOAC International 100(3) (2017) 717-720.
77. Y. Tu, L. Gu, D. Chen, W. Wu, H. Liu, H. Hu, Y. Wan, W. Sun, Rhein Inhibits Autophagy in Rat Renal Tubular Cells by Regulation of AMPK/mTOR Signaling, Scientific reports 7 (2017) 43790.